Long-term safety and efficacy of the PI3K inhibitor copanlisib in patients with relapsed or refractory indolent lymphoma:2-year follow-up of the CHRONOS-1 study

Year of publication

2020

Authors

Dreyling, Martin; Santoro, Armando; Mollica, Luigina; Leppae, Sirpa; Follows, George; Lenz, Georg; Kim, Won Seog; Nagler, Arnon; Dimou, Maria; Demeter, Judit; Oezcan, Muhit; Kosinova, Marina; Bouabdallah, Krimo; Morschhauser, Franck; Stevens, Don A.; Trevarthen, David; Munoz, Javier; Rodrigues, Liana; Hiemeyer, Florian; Miriyala, Ashok

Organizations and authors

Helsinki University Hospital

Leppae Sirpa

University of Helsinki

Leppae Sirpa

Publication type

Publication format

Article

Parent publication type

Journal

Article type

Original article

Audience

Scientific

Peer-reviewed

Peer-Reviewed

MINEDU's publication type classification code

A1 Journal article (refereed), original research

Publication channel information

Journal/Series

American journal of hematology

Parent publication name

American Journal of Hematology

Volume

Issue

Pages

362-371

ISSN

0361-8609

Publication forum

50890

Publication forum level

Open access

Open access in the publisher’s service

Yes

Open access of publication channel

Partially open publication channel

License of the publisher’s version

CC BY

Self-archived

Yes

Other information

Fields of science

Cancers

Keywords

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Publication country

United States

Internationality of the publisher

International

Language

English

International co-publication

Yes

Co-publication with a company

Yes

DOI

10.1002/ajh.25711

The publication is included in the Ministry of Education and Culture’s Publication data collection

Yes